Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Artificial Cells Designed to Power Medical Implants

By LabMedica International staff writers
Posted on 05 Nov 2008
Scientists have created a blueprint for artificial cells that are more robust and efficient than the natural cells they imitate, and could one day be used to power tiny medical implants. More...


The researchers, from Yale University (New Haven, CT, USA), began with the question of whether an artificial version of the electrocyte--the energy-generating cells in electric eels--could be designed as a potential power source. "The electric eel is very efficient at generating electricity,” said Dr. Jian Xu, a postdoctoral associate in Yale's department of chemical engineering. "It can generate more electricity than a lot of electrical devices.”

Dr. Xu came up with the first blueprint that shows how the electrocyte's different ion channels work together to produce the fish's electricity while he was a graduate student under former Yale assistant professor of mechanical engineering Dr. David LaVan, now at the U.S. National Institute of Standards and Technology. "We're still trying to understand how the mechanisms in these cells work,” said Dr. LaVan. "But we asked ourselves: ‘Do we know enough to sit down and start thinking about how to build these things?' Nobody had really done that before.”

Using the new blueprint as a guide, the investigators started out by designing an artificial cell that could replicate the electrocyte's energy production. "We wanted to see if nature had already optimized the power output and energy conversion efficiency of this cell,” Dr. said Xu. "And we found that an artificial cell could actually outperform a natural cell, which was a very surprising result.”

The artificial cell the researchers modeled is capable of producing 28% more electricity than the eel's own electrocyte, with 31% more efficiency in converting the cell's chemical energy--derived from the eel's food--into electricity. While eels use thousands of electrocytes to produce charges of up to 600 volts, Drs. LaVan and Xu demonstrated that it would be possible to create a smaller "bio-battery” using several dozen artificial cells. The tiny bio-batteries would only need to be about 6.3 mm thick to produce the small voltages needed to power tiny electrical devices such as retinal implants or other prostheses.

Although the engineers came up with a design, it will still be some time before the artificial cells are actually constructed. For one thing, they still need a power source before they could start producing electricity. Dr. LaVan hypothesizes that the cells could be powered in a way similar to their natural counterparts. It is possible, he noted, that bacteria could be employed to recycle adenosine triphosphate (ATP)--responsible for transferring energy within the cell--using glucose, a common source of chemical energy derived from food.

With an energy source in place, the artificial cells could one day power medical implants and would provide a big advantage over battery-operated devices. "If it breaks, there are no toxins released into your system,” said Dr. Xu. "It would be just like any other cell in your body.”

The study was published October 2008 in the online issue of the journal Nature Nanotechnology.

Related Links:
Yale University


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.